The platform will undergo maintenance on Sep 14 at about 9:30 AM EST and will be unavailable for approximately 1 hour.
2017
DOI: 10.1016/j.celrep.2017.10.029
|View full text |Cite
|
Sign up to set email alerts
|

The mTORC1 Signaling Network Senses Changes in Cellular Purine Nucleotide Levels

Abstract: mTORC1 integrates signals from growth factors and nutrients to control biosynthetic processes, including protein, lipid and nucleic acid synthesis. We find that the mTORC1 pathway is responsive to changes in purine nucleotides in a manner analogous to its sensing of amino acids. Depletion of cellular purines, but not pyrimidines, inhibits mTORC1, and restoration of intracellular adenine nucleotides via addition of exogenous purine nucleobases or nucleosides acutely reactivates mTORC1. Adenylate sensing by mTOR… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

17
173
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
5
1
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 164 publications
(191 citation statements)
references
References 37 publications
(51 reference statements)
17
173
1
Order By: Relevance
“…Mizoribine also exhibited greater selectivity than MPA in 3 isogenic pairs of TSC2-deficient or -expressing cell lines: a murine Tsc2 -/renal tumor-derived cell line (105K cell line) and a human TSC2 -/renal angiomyolipoma-derived cell line (621-101 cell line), both stably reconstituted with either wild-type TSC2 or empty vector, and HeLa cells with stable shRNA-mediated knockdown of TSC2 or nontargeting control ( Figure 1B Figure 2A). Consistent with previous reports (27,28), higher doses of MPA and AVN-944 reduced mTORC1 signaling in wild-type cells, as measured by phosphorylation of the mTORC1 substrate S6K, likely due to their reported effects on the protein levels of Rheb 36 , whereas mizoribine did not affect Rheb levels or mTORC1 activity ( Figure 1C).…”
Section: Resultssupporting
confidence: 92%
See 1 more Smart Citation
“…Mizoribine also exhibited greater selectivity than MPA in 3 isogenic pairs of TSC2-deficient or -expressing cell lines: a murine Tsc2 -/renal tumor-derived cell line (105K cell line) and a human TSC2 -/renal angiomyolipoma-derived cell line (621-101 cell line), both stably reconstituted with either wild-type TSC2 or empty vector, and HeLa cells with stable shRNA-mediated knockdown of TSC2 or nontargeting control ( Figure 1B Figure 2A). Consistent with previous reports (27,28), higher doses of MPA and AVN-944 reduced mTORC1 signaling in wild-type cells, as measured by phosphorylation of the mTORC1 substrate S6K, likely due to their reported effects on the protein levels of Rheb 36 , whereas mizoribine did not affect Rheb levels or mTORC1 activity ( Figure 1C).…”
Section: Resultssupporting
confidence: 92%
“…The greater antitumor efficacy of mizoribine compared with MMF likely results from a greater depletion of tumor guanylate nucleotides in response to mizoribine ( Figure 5C). Unlike mizoribine, MMF was found to partially inhibit mTORC1 signaling, possibly resulting from the partial depletion of tumor adenylates, which are sensed by mTORC1 and required for its activity (27). mTORC1 inhibition could limit the rate of guanylate nucleotide depletion, and thus the antitumor efficacy of MMF, by reducing rRNA synthesis and thus nucleotide demand.…”
Section: Discussionmentioning
confidence: 99%
“…The black line with an arrow represents the activation process and the red line with a rectangular bar at the end represents the suppression process. (Ballif et al, 2005;Campos et al, 2016;Corradetti, Inoki, Bardeesy, DePinho, & Guan, 2004;Ellisen, 2005;Gao et al, 2015;Hoxhaj et al, 2017;Huang, Wu, Wu, & Manning, 2009;Inoki et al, 2006;Inoki, Li, Zhu, Wu, & Guan, 2002;Natarajan, Trivedi-Vyas, & Wairkar, 2013;Sofer, Lei, Johannessen, & Ellisen, 2005;Zhang et al, 2003) variants have been sought in DNA from blood. However, when the analysis is negative and the patient has a clinical diagnosis but a mild phenotype, clinicians should consider mosaicism and may try to analyze a different tissue, such as buccal smear, skin biopsy of a facial angiofibroma or of a hypomelanotic macule, brain or renal tissue if surgery is going to be performed.…”
Section: Mosaicism and No Mutation Identifiedmentioning
confidence: 99%
“…Recently, mTOR was shown to promote purine biosynthesis (Ben-Sahra et al, 2016), in part as a mechanism to support ribosomal biogenesis (Valvezan et al, 2017). Conversely, purine levels have been shown to regulate mTORC1 activity (Emmanuel et al, 2017;Hoxhaj et al), highlighting an intimate relationship between mTOR and purine nucleotides. Furthermore, mTOR is reported to act downstream of store operated calcium entry to promote metabolic alterations required for T cell activation (Vaeth et al, 2017).…”
Section: Stim1 and Mtor Regulate Impdh Filament Assemblymentioning
confidence: 99%